AngioDynamics Inc.

Find Ratings Reports
ANGO : NASDAQ : Health Technology
$16.76 -0.1 | -0.59%
Today's Range: 16.76 - 17.15
Avg. Daily Volume: 223300.0
03/19/18 - 9:34 AM ET

Financial Analysis

ANGIODYNAMICS INC's gross profit margin for the second quarter of its fiscal year 2017 is essentially unchanged when compared to the same period a year ago. Sales and net income have dropped, although the growth in revenues underperformed the average competitor within the industry, the net income growth did not. ANGIODYNAMICS INC has strong liquidity. Currently, the Quick Ratio is 1.56 which shows the ability to cover short-term cash needs. The company's liquidity has decreased from the same period last year, indicating deteriorating cash flow.

During the same period, stockholders' equity ("net worth") has remained unchanged from the same quarter last year. The key liquidity measurements indicate that the company is unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit

Income Statement Q2 FY17 Q2 FY16
Net Sales ($mil)86.7189.03
EBITDA ($mil)11.8613.84
EBIT ($mil)5.977.7
Net Income ($mil)0.2513.73

Balance Sheet Q2 FY17 Q2 FY16
Cash & Equiv. ($mil)51.1236.87
Total Assets ($mil)697.81712.17
Total Debt ($mil)93.97115.16
Equity ($mil)521.22523.35

Profitability Q2 FY17 Q2 FY16
Gross Profit Margin51.2952.86
EBITDA Margin13.6715.54
Operating Margin6.898.65
Sales Turnover0.50.5
Return on Assets-1.4-3.85
Return on Equity-1.88-5.24
Debt Q2 FY17 Q2 FY16
Current Ratio2.562.91
Interest Expense0.760.81
Interest Coverage7.869.51

Share Data Q2 FY17 Q2 FY16
Shares outstanding (mil)37.1136.51
Div / share0.00.0
Book value / share14.0414.34
Institutional Own % n/a n/a
Avg Daily Volume228721.0211302.0


HOLD. The current P/E ratio is negative, which has no meaningful value in the assessment of premium or discount valuation, it simply displays that the company has negative earnings. For additional comparison, its price-to-book ratio of 1.20 indicates a significant discount versus the S&P 500 average of 3.28 and a significant discount versus the industry average of 5.73. The price-to-sales ratio is below the S&P 500 average and is well below the industry average, indicating a discount. After reviewing these and other key valuation criteria, ANGIODYNAMICS INC proves to trade at a discount to investment alternatives within the industry.

1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
ANGO NM Peers 115.38   ANGO 13.39 Peers 46.03

Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings.

ANGO's P/E is negative making this valuation measure meaningless.


Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

ANGO is trading at a significant discount to its peers.

1 2 3 4 5
premium   discount
  Price to
1 2 3 4 5
premium   discount
ANGO 18.68 Peers 32.67   ANGO NA Peers 0.78

Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.

ANGO is trading at a significant discount to its peers.


Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

Ratio not available.

1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
ANGO 1.20 Peers 5.73   ANGO 65.79 Peers 3.03

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

ANGO is trading at a significant discount to its peers.


Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

ANGO is expected to have an earnings growth rate that significantly exceeds its peers.

1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
ANGO 1.80 Peers 6.04   ANGO -3.28 Peers 17.05

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

ANGO is trading at a significant discount to its industry on this measurement.


Lower. A sales growth rate that trails the industry implies that a company is losing market share.

ANGO significantly trails its peers on the basis of sales growth



Latest Stock Upgrades/Downgrades